nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ABCB1—Topotecan—cervical cancer	0.335	0.625	CbGbCtD
Ergotamine—CYP3A4—Topotecan—cervical cancer	0.201	0.375	CbGbCtD
Ergotamine—HTR1E—female gonad—cervical cancer	0.00803	0.0557	CbGeAlD
Ergotamine—ADRA1D—epithelium—cervical cancer	0.00727	0.0504	CbGeAlD
Ergotamine—ADRA1B—renal system—cervical cancer	0.0069	0.0478	CbGeAlD
Ergotamine—ADRA1D—female reproductive system—cervical cancer	0.0054	0.0375	CbGeAlD
Ergotamine—HTR2B—uterine cervix—cervical cancer	0.00502	0.0348	CbGeAlD
Ergotamine—HTR2B—decidua—cervical cancer	0.00478	0.0331	CbGeAlD
Ergotamine—HTR2B—endometrium—cervical cancer	0.00454	0.0315	CbGeAlD
Ergotamine—SLC6A2—decidua—cervical cancer	0.00425	0.0294	CbGeAlD
Ergotamine—HTR1A—renal system—cervical cancer	0.0042	0.0292	CbGeAlD
Ergotamine—HTR2B—uterus—cervical cancer	0.00418	0.029	CbGeAlD
Ergotamine—ADRA1A—epithelium—cervical cancer	0.00418	0.029	CbGeAlD
Ergotamine—HTR1B—female reproductive system—cervical cancer	0.00417	0.0289	CbGeAlD
Ergotamine—HTR1D—female reproductive system—cervical cancer	0.00404	0.028	CbGeAlD
Ergotamine—HTR2C—female reproductive system—cervical cancer	0.004	0.0277	CbGeAlD
Ergotamine—ADRA1A—renal system—cervical cancer	0.00388	0.0269	CbGeAlD
Ergotamine—HTR2B—female reproductive system—cervical cancer	0.00376	0.0261	CbGeAlD
Ergotamine—HTR2B—vagina—cervical cancer	0.0034	0.0236	CbGeAlD
Ergotamine—SLC6A2—female reproductive system—cervical cancer	0.00334	0.0232	CbGeAlD
Ergotamine—CYP1A2—renal system—cervical cancer	0.0032	0.0222	CbGeAlD
Ergotamine—ADRA2A—uterine cervix—cervical cancer	0.00315	0.0218	CbGeAlD
Ergotamine—ADRA2A—decidua—cervical cancer	0.003	0.0208	CbGeAlD
Ergotamine—ADRA2A—endometrium—cervical cancer	0.00285	0.0198	CbGeAlD
Ergotamine—ADRA2A—mammalian vulva—cervical cancer	0.00276	0.0191	CbGeAlD
Ergotamine—HTR2A—epithelium—cervical cancer	0.0027	0.0187	CbGeAlD
Ergotamine—ADRA2A—uterus—cervical cancer	0.00263	0.0182	CbGeAlD
Ergotamine—HTR2A—renal system—cervical cancer	0.00251	0.0174	CbGeAlD
Ergotamine—ADRA2A—female reproductive system—cervical cancer	0.00236	0.0164	CbGeAlD
Ergotamine—CYP3A4—renal system—cervical cancer	0.00232	0.0161	CbGeAlD
Ergotamine—HTR2B—lymph node—cervical cancer	0.0022	0.0152	CbGeAlD
Ergotamine—ADRA2A—female gonad—cervical cancer	0.00215	0.0149	CbGeAlD
Ergotamine—ADRA2A—vagina—cervical cancer	0.00213	0.0148	CbGeAlD
Ergotamine—HTR2A—female reproductive system—cervical cancer	0.00201	0.0139	CbGeAlD
Ergotamine—SLC6A2—lymph node—cervical cancer	0.00195	0.0135	CbGeAlD
Ergotamine—CYP3A4—female reproductive system—cervical cancer	0.00186	0.0129	CbGeAlD
Ergotamine—HTR2A—vagina—cervical cancer	0.00181	0.0126	CbGeAlD
Ergotamine—ABCB1—epithelium—cervical cancer	0.00177	0.0123	CbGeAlD
Ergotamine—ABCB1—uterine cervix—cervical cancer	0.00176	0.0122	CbGeAlD
Ergotamine—ABCB1—decidua—cervical cancer	0.00167	0.0116	CbGeAlD
Ergotamine—ABCB1—renal system—cervical cancer	0.00164	0.0114	CbGeAlD
Ergotamine—ABCB1—endometrium—cervical cancer	0.00159	0.011	CbGeAlD
Ergotamine—ABCB1—mammalian vulva—cervical cancer	0.00154	0.0106	CbGeAlD
Ergotamine—ABCB1—uterus—cervical cancer	0.00146	0.0101	CbGeAlD
Ergotamine—ADRA2A—lymph node—cervical cancer	0.00138	0.00957	CbGeAlD
Ergotamine—ABCB1—female reproductive system—cervical cancer	0.00131	0.00912	CbGeAlD
Ergotamine—ABCB1—female gonad—cervical cancer	0.0012	0.0083	CbGeAlD
Ergotamine—ABCB1—vagina—cervical cancer	0.00119	0.00825	CbGeAlD
Ergotamine—ABCB1—lymph node—cervical cancer	0.000769	0.00533	CbGeAlD
Ergotamine—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000336	0.00105	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000329	0.00103	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—WNT2—cervical cancer	0.000318	0.000996	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.000316	0.000989	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.000315	0.000988	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.000315	0.000986	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—WNT2—cervical cancer	0.000312	0.000976	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.00031	0.00097	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000305	0.000956	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000305	0.000954	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000305	0.000954	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000304	0.000952	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000303	0.000949	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.000303	0.000947	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.000298	0.000934	CbGpPWpGaD
Ergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000297	0.000929	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.000293	0.000917	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—WNT5A—cervical cancer	0.00029	0.000908	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TAAR6—cervical cancer	0.00029	0.000907	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000279	0.000875	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000277	0.000868	CbGpPWpGaD
Ergotamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000276	0.000865	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKAP13—cervical cancer	0.000274	0.000857	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—WNT2—cervical cancer	0.000272	0.000853	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000267	0.000837	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000267	0.000836	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NOTCH2—cervical cancer	0.000265	0.000829	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000263	0.000824	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000263	0.000823	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000258	0.000807	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000257	0.000805	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.000257	0.000805	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NOTCH2—cervical cancer	0.00025	0.000782	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000249	0.000779	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.000246	0.00077	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000241	0.000755	CbGpPWpGaD
Ergotamine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000239	0.00075	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000239	0.000749	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000239	0.000749	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000239	0.000748	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000237	0.000743	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.000236	0.000739	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000236	0.000739	CbGpPWpGaD
Ergotamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000229	0.000718	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000226	0.000708	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000222	0.000695	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—HES1—cervical cancer	0.000217	0.00068	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000216	0.000676	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CA9—cervical cancer	0.000211	0.00066	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000208	0.000653	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000208	0.000653	CbGpPWpGaD
Ergotamine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000208	0.000651	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000207	0.000649	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000206	0.000646	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000205	0.000642	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—HES1—cervical cancer	0.000205	0.000641	CbGpPWpGaD
Ergotamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000204	0.000637	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000201	0.000629	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000198	0.000621	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TERT—cervical cancer	0.00019	0.000595	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000188	0.000589	CbGpPWpGaD
Ergotamine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000187	0.000586	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000187	0.000584	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000186	0.000584	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000183	0.000573	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000181	0.000568	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.00018	0.000564	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00018	0.000563	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TERT—cervical cancer	0.000179	0.000562	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000179	0.00056	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000176	0.000552	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—FGFR3—cervical cancer	0.000175	0.000546	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000171	0.000536	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000169	0.00053	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000166	0.000519	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—FGFR3—cervical cancer	0.000165	0.000515	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NOTCH1—cervical cancer	0.000164	0.000513	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000164	0.000513	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000158	0.000495	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000156	0.000488	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000155	0.000487	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NOTCH1—cervical cancer	0.000155	0.000484	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000152	0.000476	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—EGFR—cervical cancer	0.000146	0.000457	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CA9—cervical cancer	0.000146	0.000456	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000145	0.000454	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000144	0.00045	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000141	0.000443	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000139	0.000435	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—EGFR—cervical cancer	0.000138	0.000431	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000136	0.000426	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000131	0.00041	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000128	0.0004	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000126	0.000395	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000126	0.000393	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MTOR—cervical cancer	0.000123	0.000384	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000122	0.000381	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000121	0.000378	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.00012	0.000377	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000119	0.000373	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000119	0.000372	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CA9—cervical cancer	0.000116	0.000364	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MTOR—cervical cancer	0.000116	0.000363	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CASP3—cervical cancer	0.000113	0.000354	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000112	0.00035	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000112	0.000349	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000111	0.000347	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000109	0.000342	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000109	0.000342	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CTNNB1—cervical cancer	0.000109	0.000341	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000107	0.000336	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000107	0.000334	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CASP3—cervical cancer	0.000107	0.000334	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—cervical cancer	0.000106	0.00033	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000105	0.000328	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000104	0.000326	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000104	0.000324	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000103	0.000322	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	0.000103	0.000322	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000103	0.000321	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000103	0.000321	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	9.92e-05	0.000311	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HES1—cervical cancer	9.86e-05	0.000309	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	9.64e-05	0.000302	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	9.55e-05	0.000299	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—STAT3—cervical cancer	9.49e-05	0.000297	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TERT—cervical cancer	9.4e-05	0.000294	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—EGFR—cervical cancer	9.34e-05	0.000292	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—EGFR—cervical cancer	9.14e-05	0.000286	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HES1—cervical cancer	9.09e-05	0.000285	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TERT—cervical cancer	9.07e-05	0.000284	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TERT—cervical cancer	9.02e-05	0.000283	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CA9—cervical cancer	8.98e-05	0.000281	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	8.97e-05	0.000281	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—STAT3—cervical cancer	8.95e-05	0.00028	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—HES1—cervical cancer	8.94e-05	0.00028	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HES1—cervical cancer	8.76e-05	0.000274	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TERT—cervical cancer	8.64e-05	0.00027	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—EGFR—cervical cancer	8.62e-05	0.00027	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	8.62e-05	0.00027	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	8.59e-05	0.000269	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—MTHFR—cervical cancer	8.55e-05	0.000268	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	8.32e-05	0.000261	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	8.28e-05	0.000259	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HES1—cervical cancer	8.14e-05	0.000255	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EGFR—cervical cancer	8.14e-05	0.000255	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	8.1e-05	0.000254	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—cervical cancer	8.01e-05	0.000251	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	7.99e-05	0.00025	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TERT—cervical cancer	7.96e-05	0.000249	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	7.93e-05	0.000248	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MTOR—cervical cancer	7.85e-05	0.000246	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TERT—cervical cancer	7.84e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	7.82e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	7.78e-05	0.000243	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MTOR—cervical cancer	7.69e-05	0.000241	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TERT—cervical cancer	7.67e-05	0.00024	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	7.44e-05	0.000233	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FGFR3—cervical cancer	7.31e-05	0.000229	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—cervical cancer	7.24e-05	0.000227	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MTOR—cervical cancer	7.22e-05	0.000226	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CASP3—cervical cancer	7.22e-05	0.000226	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	7.21e-05	0.000226	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	7.19e-05	0.000225	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TERT—cervical cancer	7.13e-05	0.000223	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CASP3—cervical cancer	7.07e-05	0.000221	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	7.04e-05	0.00022	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	6.96e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	6.96e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	6.93e-05	0.000217	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	6.86e-05	0.000215	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—cervical cancer	6.83e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	6.82e-05	0.000213	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	6.75e-05	0.000211	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	6.72e-05	0.00021	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CASP3—cervical cancer	6.64e-05	0.000208	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	6.63e-05	0.000208	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	6.61e-05	0.000207	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	6.54e-05	0.000205	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	6.4e-05	0.0002	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	6.18e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	6.14e-05	0.000192	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—EGFR—cervical cancer	6.11e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—STAT3—cervical cancer	6.07e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	6.07e-05	0.00019	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	6.02e-05	0.000188	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	5.96e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—STAT3—cervical cancer	5.94e-05	0.000186	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—cervical cancer	5.91e-05	0.000185	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	5.89e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MTOR—cervical cancer	5.86e-05	0.000183	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MTOR—cervical cancer	5.83e-05	0.000182	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—STAT3—cervical cancer	5.58e-05	0.000175	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	5.58e-05	0.000175	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	5.58e-05	0.000175	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EGFR—cervical cancer	5.51e-05	0.000173	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	5.47e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EGFR—cervical cancer	5.4e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CASP3—cervical cancer	5.39e-05	0.000169	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	5.38e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CASP3—cervical cancer	5.36e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	5.19e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	5.19e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	5.17e-05	0.000162	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MTOR—cervical cancer	5.14e-05	0.000161	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	5.13e-05	0.000161	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EGFR—cervical cancer	5.07e-05	0.000159	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MTOR—cervical cancer	5.06e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	4.95e-05	0.000155	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	4.94e-05	0.000155	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CASP3—cervical cancer	4.73e-05	0.000148	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—cervical cancer	4.72e-05	0.000148	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	4.72e-05	0.000148	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	4.69e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CASP3—cervical cancer	4.65e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—cervical cancer	4.63e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	4.6e-05	0.000144	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	4.56e-05	0.000143	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	4.56e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—cervical cancer	4.53e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—STAT3—cervical cancer	4.53e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—STAT3—cervical cancer	4.5e-05	0.000141	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	4.49e-05	0.00014	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	4.39e-05	0.000138	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	4.31e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	4.26e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—cervical cancer	4.26e-05	0.000133	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	4.23e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EGFR—cervical cancer	4.11e-05	0.000129	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EGFR—cervical cancer	4.09e-05	0.000128	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	4.08e-05	0.000128	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—STAT3—cervical cancer	3.97e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—cervical cancer	3.96e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	3.92e-05	0.000123	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—STAT3—cervical cancer	3.91e-05	0.000122	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	3.83e-05	0.00012	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—cervical cancer	3.64e-05	0.000114	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EGFR—cervical cancer	3.61e-05	0.000113	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—cervical cancer	3.58e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	3.56e-05	0.000111	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EGFR—cervical cancer	3.55e-05	0.000111	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	3.48e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—cervical cancer	3.45e-05	0.000108	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—cervical cancer	3.44e-05	0.000108	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—cervical cancer	3.29e-05	0.000103	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	3.23e-05	0.000101	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—cervical cancer	3.03e-05	9.49e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—cervical cancer	2.98e-05	9.34e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—cervical cancer	2.92e-05	9.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—cervical cancer	2.71e-05	8.5e-05	CbGpPWpGaD
